Brief: Chugai Pharmaceutical Says It And Miraca Enter Into Business Partnership Agreement For "Foundationone Cdx Cancer Genome Profile"
19/03/2019 06:06
March 19 (Reuters) - Chugai Pharmaceutical Co Ltd 4519.T :
* MIRACA AND CHUGAI ENTER INTO BUSINESS PARTNERSHIP
AGREEMENT FOR
"FOUNDATIONONE CDX CANCER GENOME PROFILE"
Source text for Eikon: ID:nTSOS78360
Further company coverage: 4519.T
(Reporting By Chris Gallagher)
((chris.gallagher@thomsonreuters.com;))
Recent news on Chugai Pharmaceutical
See all newsRegarding Discontinuation Of Development Of Gym329 (Emugrobart) For Obesity, Return Of License And Resumption Of Development For SMA
Table: Chugai Pharm 6-MTH group results (IFRS)
Japan's Nikkei roars past 62,000 on earnings, Middle East optimism; JGBs rally (updated)
Japan's Nikkei surges past 61,000 for first time on earnings, Mideast optimism
Japan's Nikkei closes above 60,000 for first time on earnings optimism (updated)